Post by SkywalkerofLukeon Jan 02, 2025 5:48pm
Good recap of Thiogenesis Therapeutics Corp. (TTI.v TTIPF) and the development of the drug TTI-0102 which is designed to treat pediatric NASH by releasing cysteamine, a potent antioxidant that can
...more